Vir Biotechnology Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.88

+0.28 (+2.64%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +56.1% upside

Low Target $13.41

Average Target $16.98

High Target $22.24

Current Price $10.88

Current
$10.88

Target
$16.98

$13.41 $16.98 avg $22.24

Scenario Analysis

Bear Case

$13.41

23.3%

Low target

Base Case

$16.98

+56.1%

Avg target

Bull Case

$22.24

+104.4%

High target

Risk/Reward

4.5x

Highly favorable

Price in Context

52-Week High

$11.94

-8.9% from high

52-Week Low

$4.78

+127.6% from low

Target vs 52W High

$16.98

+42.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%